Senior Director, Compliance, Europe

Das ist der Job

The Opportunity RevMed is seeking an experienced compliance leader in Europe.

Darum lohnt es sich

As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway.

As a key member of the Legal and Compliance function, this is an excellent opportunity to lead a team and support the launch of new RevMed therapies and the Company’s rapid business growth in Europe. Key Responsibilities Represent Compliance as the Compliance lead on the European Leadership team.

Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS‑addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins.

The company’s RAS(ON) inhibitors daraxonrasib (RMC‑6236), a RAS(ON) multi‑selective inhibitor; elironrasib (RMC‑6291), a RAS(ON) G12C‑selective inhibitor; zoldonrasib (RMC‑9805), a RAS(ON) G12D‑selective inhibitor; and RMC‑5127, a RAS(ON) G12V‑selective inhibitor, are currently in clinical development.

The position will contribute to the development and implementation of organizational strategies, policies and practices, and work with senior Commercial, Medical, Clinical Development, Legal, Finance and HR leadership to integrate appropriate healthcare, corporate and other compliance controls to guide the Company’s operations.

Collaborate with cross-regions and